Metraipolis › archive › dc_2bc1f956e9cf
Monocyte-derived transcriptome signature indicates antibody-dependent cellular phagocytosis as a potential mechanism of vaccine-induced protection against HIV-1 — Europe PMC PMID:34533134
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/34533134
- DOI
- 10.7554/elife.69577
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-02T19:08:45.686Z
- SHA-256 of the archived text
8b9bb06f264b3858584597f2df7893943ecfa4c7f8dcbe118fe4f961fea17814- Stable URL of this page
https://metraipolis.com/documento/dc_2bc1f956e9cf
How to cite
Monocyte-derived transcriptome signature indicates antibody-dependent cellular phagocytosis as a potential mechanism of vaccine-induced protection against HIV-1 — Europe PMC PMID:34533134 — Europe PMC (en), https://europepmc.org/article/MED/34533134 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_2bc1f956e9cf (Metraipolis archive dc_2bc1f956e9cf, sha256 8b9bb06f264b3858584597f2df7893943ecfa4c7f8dcbe118fe4f961fea17814)
BibTeX
@misc{dc2bc1f956e9cf,
title = {Monocyte-derived transcriptome signature indicates antibody-dependent cellular phagocytosis as a potential mechanism of vaccine-induced protection against HIV-1 — Europe PMC PMID:34533134},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/34533134},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_2bc1f956e9cf; sha256 8b9bb06f264b3858584597f2df7893943ecfa4c7f8dcbe118fe4f961fea17814},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/34533134. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
A gene signature was previously found to be correlated with mosaic adenovirus 26 vaccine protection in simian immunodeficiency virus and simian-human immunodeficiency virus challenge models in non-human primates. In this report, we investigated the presence of this signature as a correlate of reduced risk in human clinical trials and potential mechanisms of protection. The absence of this gene signature in the DNA/rAd5 human vaccine trial, which did not show efficacy, strengthens our hypothesis that this signature is only enriched in studies that demonstrated protection. This gene signature was enriched in the partially effective RV144 human trial that administered the ALVAC/protein vaccine, and we find that the signature associates with both decreased risk of HIV-1 acquisition and increased vaccine efficacy (VE). Total RNA-seq in a clinical trial that used the same vaccine regimen as the RV144 HIV vaccine implicated antibody-dependent cellular phagocytosis (ADCP) as a potential mechanism of vaccine protection. CITE-seq profiling of 53 surface markers and transcriptomes of 53,777 single cells from the same trial showed that genes in this signature were primarily expressed in cells belonging to the myeloid lineage, including monocytes, which are major effector cells for ADCP. The consistent association of this transcriptome signature with VE represents a tool both to identify potential mechanisms, as with ADCP here, and to screen novel approaches to accelerate the development of new vaccine candidates. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: eLife, 2021 (prima pubblicazione 2021-09-17). Identificativi: PMID 34533134 · PMCID PMC8514236 · DOI 10.7554/elife.69577. Parole chiave degli autori: Human; Microbiology; Single cell; Infectious disease; Rhesus macaque; ADCP; Hiv Vaccine; Transcriptomics; Vaccine Efficacy; Cite-seq. Descrittori MeSH principali: Gene Expression Profiling; Transcriptome. Pagina: https://europepmc.org/article/MED/34533134 — https://doi.org/10.7554/elife.69577. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-02T19:01:29.111Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.